PAA 2.38% 20.5¢ pharmaust limited

Ann: Inhibition of SARS-CoV-2 by MPL in Human Respiratory Cells, page-133

  1. 228 Posts.
    lightbulb Created with Sketch. 40
    This last bit of the ann is what interests me the most;
    This data will fuel further development of the effects of monepantel administration upon SARS-CoV-2 for clinical application”.
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.